United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - dydrogesterone; estradiol - oral tablet - 5mg ; 1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - estradiol; dydrogesterone - oral tablet - 500microgram ; 2.5mg

Australia - English - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - progesterone, quantity: 200 mg - pessary, moulded - excipient ingredients: hard fat - oripro pessaries are indicated for:,1. assisted reproductive technology (art) treatment of infertile women with progesterone deficiency, requiring progesterone supplementation or replacement to support embryo implantation and maintain initial pregnancy.,2. prevention of preterm birth in singleton pregnancies at risk due to:,- shortened cervix (midtrimester sonographic cervix less than or equal to 25 mm). and/or,- where there is a history of spontaneous preterm birth.

Australia - English - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - progesterone, quantity: 100 mg - pessary, moulded - excipient ingredients: hard fat - oripro pessaries are indicated for:,1. assisted reproductive technology (art) treatment of infertile women with progesterone deficiency, requiring progesterone supplementation or replacement to support embryo implantation and maintain initial pregnancy.,2. prevention of preterm birth in singleton pregnancies at risk due to:,- shortened cervix (midtrimester sonographic cervix less than or equal to 25 mm). and/or,- where there is a history of spontaneous preterm birth.

Malta - English - Medicines Authority

mylan products limited - dydrogesterone; estradiol - film-coated tablet - dydrogesterone 5 mg; estradiol 1 mg - sex hormones and modulators of the genital system

Malta - English - Medicines Authority

mylan products limited - dydrogesterone; estradiol - film-coated tablet - dydrogesterone 2.5 mg; estradiol 0.5 mg - sex hormones and modulators of the genital system

United States - English - NLM (National Library of Medicine)

a-s medication solutions - ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u), norethindrone acetate (unii: 9s44lic7oj) (norethindrone - unii:t18f433x4s) - norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective. table i lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. % of women experiencing an unintended pregnancy in the first year of continuous use method lowest expected* typical** (no contraception)  (85) (85) oral contraceptives  3       combined  0.1 n/a ***       progestin only  0.5 n/a *** diaphragm with spermicidal cream or jelly  6 20 spermicides alone (foam, creams, gels, vaginal suppositories and vaginal film)  6 26 vaginal sponge       nulliparous  9 20       parous 20 40 implant  0.05 0.05 inj

Malta - English - Medicines Authority

mylan ire healthcare limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - dydrogesterone, estradiol - film-coated tablet - dydrogesterone 5 mg estradiol 1 mg - sex hormones and modulators of the genital system

Israel - English - Ministry of Health

abbott medical laboratories ltd, israel - dydrogesterone; estradiol; estradiol - film coated tablets - dydrogesterone 10 mg; estradiol 1 mg; estradiol 1 mg - dydrogesterone and estrogen - hormone replacement therapy (hrt) for estrogen deficiency symptoms in menopausal women at least 6 months since last menses.prevention of osteoporosis in postmenopausal women at high risk of future fractures. femoston 1/10 should only be used in patients who are intolerant of other products, approved for the prevention of osteoporosis or for whom these products are contra-indicated.femoston is indicated for women with an intact uterusexperience with treatment of women older than 65 years is limited.

Israel - English - Ministry of Health

abbott medical laboratories ltd, israel - dydrogesterone; estradiol as hemihydrate - film coated tablets - dydrogesterone 2.5 mg; estradiol as hemihydrate 0.5 mg - dydrogesterone and estrogen - hormone replacement therapy (hrt) for estrogen deficiency symptoms in postmenopausal women at least 12 months since last menses.femoston is indicated for women with an intact uterus